medigraphic.com
SPANISH

Acta Médica Grupo Angeles

Órgano Oficial del Hospital Angeles Health System
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
    • Names and affiliations of the Editorial Board
  • Policies
  • About us
    • Data sharing policy
    • Stated aims and scope
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 2

<< Back Next >>

Acta Med 2022; 20 (2)

Trichosporon asahii pneumonia in an immunocompetent patient

Becerril NJM, Moreno OL, Díaz GEJ, Cornelio RG
Full text How to cite this article 10.35366/104282

DOI

DOI: 10.35366/104282
URL: https://dx.doi.org/10.35366/104282

Language: Spanish
References: 14
Page: 181-184
PDF size: 167.83 Kb.


Key words:

Trichosporonosis, Trichosporon asahii, nosocomial pneumoniae, fungosi.

ABSTRACT

Trichosporonosis is a rare fungal infection, with high mortality in immunocompromised patients, its presentation in immunocompetent patients is even rarer. We present the case of a 66-year-old male immunocompetent patient who presented pneumonia, secondary to a perforation in the gastrointestinal tract and invasive respiratory support, with the unfavorable outcome and extended stay in the intensive care unit, until positive culture for Trichosporon asahii was reported and specific treatment was administered.


REFERENCES

  1. Tamayo Lomasa L, Domínguez-Gil M, Martín Luengo AI, Eiros Bouza JM, Piqueras Pértez JM. Infección Nosocomial por Trichosporon asahii en un paciente quemado crítico. Rev Iberoam Micol. 2015; 32 (4): 257-260.

  2. Valladares García JC, Gallardo Grajeda LA, Salado Burbano JC, Espinosa Aguilar L. Infección por Trichosporon asahii. An Med ABC. 2018; 63 (2): 138-141.

  3. Tapia P Cecilia. Género Trichosporon. Rev Chil Infectol. 2009; 26 (3): 263-264.

  4. Odero V, Galán-Sánchez F, García-Agudo L, García-Tapia AM, Guerrero-Lozano I, Rodríguez-Iglesias MA. Fungemia por Trichosporn asahii en un paciente con neoplasia hematológica. Rev Iberoam Micol. 2015; 32 (1): 59-61.

  5. Chagas-Neto TC, Chaves GM, Colombo AL. Update on the genus Trichosporon. Mycopathologia. 2008; 166 (3): 121-132.

  6. Girmenia C, Pagano L, Martino B, D'Antonio D, Fanci R, Specchia G et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005; 43 (4): 1818-1828.

  7. Colombo AL, Padovan AC, Chavez GM. Current knowledge of Trichosporon spp. and Trichosporosis. Clin Microbiol Rev. 2011; 24 (4): 682-700.

  8. Khan ID, Sahni AK, Basu A, Haleem S. Trichosporon asahii urinary tract infection in immunocompetent patients. Med J Armed Forces India. 2015; 71 (4): 373-376.

  9. Da Silva Rodrigues G, Ubatuba de Faria RR, Silva Guazzeli L, de Mattos Oliveira F, Severo LC. Infección nosocomial por Trichosporon asahii: revisión clínica de 22 casos. Rev Iberoam Micol. 2006; 23: 85-89.

  10. Vartivarian SE, Anaissie EJ, Bodey GP. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis and management. Clin Infect Dis. 1993; 17 (Suppl 2): 487-491.

  11. Franquet T. Airway-Centered Interstitial Fibrosis. StatDx. Consultado el día 20 Septiembre 2020. Available in: https://my.statdx.com/document/airway-centered-interstitial-fibro-/67389921-f4ed-46d3-b929-021a5fd90c64?searchTerm=Trichosporon

  12. Cebollero P, Echechipía S, Echegoyen A, Lorente MP, Fanlo P. Neumonitis por hipersensibilidad (alveolitis alérgica extrínseca). Anales Sis San Navarra. 2005; 28 (Suppl. 1): 91-99.

  13. Fica C A. Tratamiento de infecciones fúngicas sistémicas Primera parte: fluconazol, itraconazol y voriconazol. Rev Chil Infectol. 2004; 21 (1): 26-38.

  14. Heslop OD, Nyi Nyi MP, Abbott SP, Rainford LE, Castle DM, Coard KC. Disseminated Trichosporonosis in a burn patient: meningitis and cerebral abscess due to Trichosporon asahii. J Clin Microbiol. 2011, 49 (12): 4405-4408.




Figure 1
Figure 2
Figure 3

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med. 2022;20